RA Capital Healthcare Fund LP, Director, 10% Owner at Tyra Biosciences, Inc. (TYRA), bought 373,700 shares at $10.19 ($3.8M) on 2025-06-09, disclosed to the SEC on 2025-06-11.
Open-market purchase of $3.8M TYRA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.19 | 186,850 | $1.9M | 50.0% |
| 2 | $10.19 | 186,850 | $1.9M | 50.0% |
| Total | $10.19 avg | 373,700 | $3.8M | 100% |
| Filing → |
| FULC | SELL | 2025-12-10 | $116.8M | — | Filing → |
| PEPG | BUY | 2025-09-30 | $30.0M | — | Filing → |
| JANX | BUY | 2025-03-07 | $50.7M | — | Filing → |